Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome

British Journal of Haematology

Volumn 101, Issue 1, 1998, Pages 50-58

  Bettache, Nadir ^a   Gaffet, Patrick ^a   Allence, Nicolas ^a   Maurin, Lucien ^a   Toti, Florence ^b   Freyssinet, Jean Marie ^b   Bienvenüe, Alain ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Activation; Blood platelet; Cell shape; Phospholipids; Scott syndrome

Indexed keywords

AMINOPHOSPHOLIPID; CALPEPTIN;

ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CELL SHAPE; CELLULAR DISTRIBUTION; CYTOSKELETON; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; HEMOSTASIS; HUMAN; HUMAN CELL; MEDIATOR RELEASE; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOCYTE ACTIVATION;

BIOLOGICAL TRANSPORT; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; CALCIMYCIN; CELL MEMBRANE; CELL SIZE; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PLATELET ACTIVATION; SYNDROME;

EID: 0031970545     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00658.x     Document Type: Article

References (40)

1. Ahmad, S., Rawla-Sheikh, R., Ashby, B. & Walsh, P. (1989) Platelet receptor-mediated factor X activation by factor IXa: high-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. Journal of Clinical Investigation, 84, 824-828.
2. Bartlett, G.R. & Korn, E.D. (1959) Phosphorus assay in column chromatography. Journal of Biological Chemistry, 234, 466-468.
3. Bassé, F., Gaffet, P. & Bienvenüe, A. (1994) Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation. Biochimica et Biophysica Acta, 1190, 217-224.
4. Bassé, F., Gaffet, P., Rendu, F. & Bienvenue, A. (1992) Phospholipid transverse mobility modifications in plasma membranes of activated platelets: an ESR study. Biochemical and Biophysical Research Communications, 189, 465-471.
5. Bassé, F., Gaffet, P., Rendu, F. & Bienvenüe, A. (1993) Translocation of spin-labeled phospholipids through plasma membrane during thrombin- and ionophore A23187-induced platelet activation. Biochemistry, 32, 2337-2344.
6. Bassé, F., Stout, J., Sims, P. & Wiedmer, T. (1996) Isolation of an erythrocyte membrane protein that mediates Ca~'-dependent transbilayer movement of phospholipid. Journal of Biological Chemistry, 271, 17205-17210.
7. Bevers, E.M., Comfurius, P. & Zwaal, R.F.A. (1982) The nature of the binding site for prothrombinase at the platelet surface as revealed by lipolytic enzymes. European Journal of Biochemistry, 122, 81-85.
8. Bevers, E.M., Comfurius, P. & Zwaal, R.F.A. (1983) Changes in membrane phospholipid distribution during platelet activation. Biochimica et Biophysica Acta, 736, 57-66.
9. Chap, H.J., Zwaal, R.F.A. & Van Deenen, L.L.M. (1977) Action of highly purified phospholipases on blood platelets: evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochimica et Biophysica Acta, 467, 146-164.
10. Comfurius, P., Bevers, E.M. & Zwaal, R.F.A. (1985) The involvement of cytoskeleton in the regulation of transbilayer movement of phospholipids in human blood platelets. Biochimica et Biophysica Acta, 815, 143-148.
11. Comfurius, P., Williamson, P., Smeets, E., Schlegel, R., Bevers, E. & Zwaal, R. (1996) Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry, 35, 7631-7634.
12. 2+ -ATPase inhibitors. Biochemistry, 34, 11625-11634.
13. Davoust, J., Seigneuret, M., Hervé, P. & Devaux, P.F. (1983) Collision between nitrogen-14 and nitrogen-15 spin-labels. 1, Lipid-lipid interactions in model membranes. Biochemistry, 22, 3137-3145.
14. Folch, J., Lees, M. & Sloane-Stanley, G.H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry, 226, 497-509.
15. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell, 80, 919-927.
16. Gaffet, P., Bettache, N. & Bienvenue, A. (1995a) Phosphatidylserine exposure on the platelet plasma membrane during A23187-induced activation is independent of cytoskeleton reorganization. European Journal of Cell Biology 67, 336-345.
17. Gaffet, P., Bettache, N. & Bienvenüe. A. (1995b) Transverse redistribution of phospholipids during human platelet activation: evidence for a vectorial outflux specific to aminophospholipids. Biochemistry, 34, 6762-6769.
18. Kojima, H., Newton-Nash, D., Weiss, H., Zhao, J., Sims, P. & Wiedmer, T. (1994) Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. Journal of Clinical Investigation. 94, 2237-2244.
19. Martin, S.J., Reutelingsperger, C.P.M., McGahon, A.J., Rader, J.A., van Schie, R.C.A.A., LaFace, D.M. & Green, D.R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. Journal of Experimental Medicine, 182, 1545-1556.
20. Miletich, J., Kane, W., Hofmann, S., Stanford, N. & Majerus, P. (1979) Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood, 54, 1015-1022.
21. Morrot, G., Hervé, P., Zachowski, A., Fellmann, P. & Devaux, P.F. (1989) Aminophospholipid translocase of human erythrocytes: phospholipid substrate specificity and effect of cholesterol. Biochemistry, 28, 3456-3462.
22. Op den Kamp, J.A.F. (1979) Lipid asymmetry in membranes. Annual Review of Biochemistry, 48, 47-71.
23. Rosing, J., Bevers, E.M., Confurius, P., Hemker, H.C., van Dieijen, G., Weiss, H.J. & Zwaal. R.F.A. (1985) Impaired factor X and prothrombine activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood, 65, 1557-1561.
24. Schick, P.K., Kuriea, K.B. & Chacko, G.K. (1976) Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. Journal of Clinical Investigation, 57, 1221-1226.
25. Seigneuret, M. & Devaux, P.F. (1984) ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proceedings of the National Academy of Sciences of the United States of America, 81, 3751-3755.
26. Sims, P.J., Faioni, E.M., Wiedmer, T. & Shattil, S.J. (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. Journal of Bioligical Chemistry, 263, 18205-18212.
27. Sims, P.J., Wiedmer, T., Esmon, C.T., Weiss, H.J. & Shattil, S.J. (1989) Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: studies in Scott syndrome, an isolated defect in platelet procoagulant activity. Journal of Biological Chemistry, 264, 17049-17057.
28. 2+ -dependent transbilayer migration of membrane phospholipids. Journal of Clinical Investigation, 99, 2232-2238.
29. Suné, A., Bette-Bobillo, P., Bienvenüe. A., Fellmann, P. & Devaux, P.F. (1987) Selective outside-inside translocation of aminophospholipids in human platelets. Biochemistry, 26, 2972-2978.
30. Suné, A. & Bienvenüe, A. (1988) Relationship between the transverse distribution of phospholipids in plasma membrane and shape change of human platelets. Biochemistry, 27, 6794-6800.
31. Toti, F., Satta. N., Fressinaud, E., Meyer, D. & Freyssinet, J.M. (1996) Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood, 87, 1409-1415.
32. Toti-Orfanoudakis, F., Satta, N., Fressinaud, E., Meyer, D. & Freyssinet, J. (1996) Le syndrome de Scott: un témoin de l'importance des phospholipides dans les réactions de la coagulation et une référence pour une nouvelle approche pharmacologique du risque thrombotique. Hématologie, 2, 111-118.
33. Valone, F.H., Coles, E., Vernon, R.R. & Goetzl, E.J. (1982) Specific binding of phospholipid platelet-activating factor by human platelets. Journal of Immunology, 129, 1637-1641.
34. van Helvoort, A., Smith, A.J., Sprong. H., Fritzsche, I., Schinkel, A.H., Borst, P. & van Meer, G. (1996) MDR1 P-glycoprotein is a lipid translocase of broad specilicity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell, 87, 507-517.
35. Weiss, H.J., Vicic. W.J., Lages, B.A. & Rogers, J. (1979) Isolated deficiency of procoagulant activity. American Journal of Medicine, 67, 206-213.
36. Williamson, P., Bevers, E.M., Smeets, E.F., Comfurius, P., Schlegel, R.A. & Zwaal, R.F.A. (1995) Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry, 34, 10448-10455.
37. Zachowski, A., Favre, E., Cribier, S., Hervé, P. & Devaux, P.F. (1986) Outside-inside translocation of aminophospholipids in the human crythrocyte membrane is mediated by a specific enzyme. Biochemistry, 25, 2585-2590.
38. Zhou, Q., Zhao, J., Stout, J., Luhm, R. Wiedmer, T. & Sims, P. (1997) Molecular cloning of human plasma membrane phospholipid scramblase: a protein mediating transbilayer movement of plasma membrane phospholipids. Journal of Biologocal Chemistry, 272, 18240-18244.
39. Zwaal, R.F.A., Bevers. E.M., Comfurius, P., Rosing, J., Tilly, R.H.J. & Verhallen, P.F.J. (1989) Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells: mechanisms and physiological significance. Molecular Cell Biochemistry, 91, 23-31.
40. Zwaal, R.F.A., Comfurius, P. & Bevers, E.M. (1992) Platelet procoagulant activity and microvesicle formation: its putative role in hemotasis and thrombosis. Biochimica et Biophysia Acta, 1180, 1-8.